AustraliaHealth

Macquarie Health, one of Australia's largest privately owned hospital groups, is preparing to terminate contracts with dozens of private health insurers.

Firebrick Pharma (ASX:FRE) has launched its first international product, Nasodine throat spray, in Singapore.

Algorae Pharmaceuticals (ASX:1AI) has secured a $3 million receivables-based working capital facility with ScotPac Business Finance.

Clinical-stage biotech company Noxopharm (ASX:NOX) has completed the HERACLES clinical trial.

Anteris Technologies Global (ASX:AVR) announced plans for a proposed US$200 million underwritten public offering of common stock.

Telix Pharmaceuticals (ASX:TLX) reported strong commercial and operational performance for the quarter ended Dec. 31, 2025, achieving its upgraded full-year FY25 revenue guidance with unaudited group revenue of approximately US$804 million.

Cambium Bio (ASX:CMB), a clinical-stage regenerative medicine company specialising in ophthalmology and tissue repair, has secured a $2.4 million strategic investment from its major shareholder, Zheng Yang Biomedical Technology.

Cancer diagnostics company Pacific Edge (ASX:PEB) has released its investor update for the three months ended December 2025.

Telix Pharmaceuticals (ASX:TLX) announced that China's National Medical Products Administration has accepted its New Drug Application for TLX591-Px .

Immuron (ASX:IMC), an Australian-based biopharmaceutical company, has announced continued unaudited sales growth for Travelan, its over-the-counter immune supplement targeting pathogenic bacteria in the gastrointestinal tract.

Mesoblast (ASX:MSB), a leader in allogeneic cellular medicines, reported that the US Food & Drug Administration has acknowledged that data from the company's first Phase 3 trial of rexlemestrocel-L for chronic discogenic low back pain favour the therapy in reducing pain intensity.

PolyNovo (ASX:PNV) reported unaudited trading results for the first half of FY26, with group revenue rising 26% to $68.2 million, compared with $54.1 million in the same period last year.